EP0200412A2
Method of conferring immunotolerance to a specific antigen.
Abstract
A method of selectively suppressing the immune system and conferring immunotolerance against a specific antigen by interferring with the L3T4 differentiation antigens on helper T cells is described. Simultaneous administration of a binding moiety specific for the L3T4 equivalent in the subject species and a specific antigen results in a dimished ability of the subject to respond immunologically to the antigen, whether or not the subject has been exposed previously to the antigen.
Term
Term ended
Projected expiry passed 15 April 2006, 20.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
5 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO9109619A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| USRE43898E1 | Cited by | United States of America | Applicant |
| US7098006B1 | Cited by | United States of America | Applicant |
| EP0240344A2 | Cited by | European Patent Office (EPO) | Examiner |
| WO9200100A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| USRE46877E | Cited by | United States of America | Applicant |
| US8722343B2 | Cited by | United States of America | Applicant |
| USRE43898E | Cited by | United States of America | Applicant |
| EP0287361A2 | Cited by | European Patent Office (EPO) | Search report |
| EP0287361A3 | Cited by | European Patent Office (EPO) | Search report |
| USRE46877E | Cited by | United States of America | Applicant |
| EP0240344B1 | Cited by | European Patent Office (EPO) | Examiner |
| EP0536807A1 | Cited by | European Patent Office (EPO) | Search report |
| US7858095B2 | Cited by | United States of America | Applicant |
| WO2010057647A3 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| AU644400B2 | Cited by | Australia | Search report |
| WO2010057647A3 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US7662921B2 | Cited by | United States of America | Applicant |
| EP0536807A1 | Cited by | European Patent Office (EPO) | Search report |
| WO2010057647A2 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US6767996B1 | Cited by | United States of America | Applicant |
| WO9200100A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US7037496B2 | Cited by | United States of America | Applicant |
| US5690933A | Cited by | United States of America | Search report |
| US7323171B2 | Cited by | United States of America | Applicant |
| EP0140109A2 | Cites | European Patent Office (EPO) | Search report |
| GB2093037A | Cites | United Kingdom | Search report |
| US4275000A | Cites | United States of America | Search report |
| US4489710A | Cites | United States of America | Search report |
11 members in 6 offices; this record represents the family
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 72406385 | United States of America | A | |
| US19850724063 | – | – | – |
| 724063 | – | – | – |
Members11
| Document | Office | Kind | |
|---|---|---|---|
| EP0200412A2This record | European Patent Office (EPO) | A2 | |
| JPS6236A | Japan | A | |
| US4681760A | United States of America | A | |
| EP0200412A3 | European Patent Office (EPO) | A3 | |
| CA1266232A | Canada | A | |
| US4904481A | United States of America | A | |
| EP0200412B1 | European Patent Office (EPO) | B1 | |
| AT64304T | Austria | T | |
| ATE64304T1 | Austria | T1 | |
| DE3679708D1 | Germany | D1 | |
| JP2530316B2 | Japan | B2 |
46 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Lu: last paid annual feeEPTA | EPTA | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation filedET | ET | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Application published (corrected)RA1 | RA1 | EP | |
| Information related to the publication of an a document modified or deletedORIGINAL CODE: 0009199EPPUPUAB | PUAB | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication, DOCDB
- 0200412
- Publication, EPODOC
- EP0200412
- Application
- 86302781
- Application, DOCDB
- 86302781
- Application, EPODOC
- EP19860302781
Titles3
- German
- Verfahren zur Verleihung von Immuntoleranz gegen ein spezifisches Antigen.
- English
- Method of conferring immunotolerance to a specific antigen.
- French
- Méthode pour conférer une tolérance immunologique vis-à-vis d'un antigène spécifique.
Classification
- CPC, 8
- A61K39/35
- A61K39/0008
- A61K39/001
- Y10S424/81
- Y10S435/81
- Y10S436/811
- A61P37/00
- A61P37/08
- IPC, 9
- A61K39 00
- A61K39 35
- A61K39 395
- A61K45 00
- A61K45 06
- A61P37 00
- A61P37 08
- C07K17 02
- C12N5 00
Designated states11
- Contracting states, 11
- Austria
- Belgium
- Switzerland
- Germany
- France
- United Kingdom
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden